ATRX公司
胶质瘤
医学
DNA甲基化
外显子组
癌症研究
外显子组测序
突变
肿瘤科
生物
遗传学
基因
基因表达
作者
Daniel J. Brat,Roel G.W. Verhaak,Kenneth D. Aldape,W. K. Alfred Yung,Sofie R. Salama,Lee Cooper,Esther Rheinbay,C. Ryan Miller,Mark Vitucci,Olena Morozova,A. Gordon Robertson,Houtan Noushmehr,Peter W. Laird,Andrew D. Cherniack,Rehan Akbani,Jason T. Huse,Giovanni Ciriello,Laila Poisson,Jill S. Barnholtz‐Sloan,Mitchel S. Berger
标识
DOI:10.1056/nejmoa1402121
摘要
The integration of genomewide data from multiple platforms delineated three molecular classes of lower-grade gliomas that were more concordant with IDH, 1p/19q, and TP53 status than with histologic class. Lower-grade gliomas with an IDH mutation either had 1p/19q codeletion or carried a TP53 mutation. Most lower-grade gliomas without an IDH mutation were molecularly and clinically similar to glioblastoma. (Funded by the National Institutes of Health.).
科研通智能强力驱动
Strongly Powered by AbleSci AI